Researchers at the Wellcome Sanger Institute and the University of Cambridge have made significant strides in understanding the functional impact of thousands of genetic changes within the DDX3X gene.
This breakthrough promises to enhance the diagnosis and treatment of various neurodevelopmental disorders and cancers, opening up new avenues for medical intervention.
Their novel approach surpasses existing methods in pinpointing the genetic basis of neurodevelopmental disorders and cancer, making it possible to identify harmful mutations on a large scale, previously deemed too intricate to decipher.
This research offers newfound prospects for the diagnosis and treatment of these conditions.
The scientists extensively investigated more than 12,000 genetic changes within the DDX3X gene, meticulously validating their functional consequences.
Approximately a quarter of these genetic changes were found to impact the gene’s function negatively, shedding light on the significance of 90% of previously unexplained genetic variations about health.
By correlating these findings with patient data, the researchers established that the loss of DDX3X function plays a substantial role in neurodevelopmental disorders and is a key driver of cancer development.
The results of this study, published in Nature Communications, unveil formerly enigmatic aspects of the human genetic code, offering valuable insights into the genetic mechanisms underpinning neurodevelopmental disorders and cancers. This breakthrough paves the way for early detection methods and innovative treatments.
The researchers anticipate that this groundbreaking technique can be broadly applied to comprehend the relevance of genetic alterations in numerous other genes concerning neurodevelopmental disorders.
The DDX3X gene has long been associated with neurodevelopmental disorders, particularly in females, as well as certain types of cancer.
These disorders are characterized by intellectual disabilities, developmental delays, and often manifest symptoms such as seizures, movement disorders, and behavioral issues.
Diagnosing these disorders presents significant challenges, especially in young children with unclear symptoms or unborn infants, resulting in misdiagnoses of other conditions like autism.
Early detection of these neurodevelopmental disorders through genetic screening can greatly enhance the effectiveness of treatment and improve the quality of life for affected individuals. However, until now, there has been limited understanding of which harmful genetic changes to look for.
In this groundbreaking study, scientists embarked on a quest to uncover the consequences of all potential genetic changes within the DDX3X gene on protein function and health, including neurodevelopmental disorders and cancer.
In contrast to computer-based predictive tools, the research team integrated real experiments to assess thousands of genetic changes by artificially altering the genetic code of human cells cultivated in a dish, a process known as “saturation genome editing.”
To comprehend the effects of these genetic alterations, they compared the experimental data with health data from the UK Biobank cohort.
The team identified 3,432 out of 12,776 distinct genetic changes hurt the protein’s function. Using this technique, they illuminated the significance of up to 93% of genetic changes, the impact of which on health was previously unknown.
They achieved an accuracy rate of at least 97% in identifying DDX3X genetic changes associated with neurodevelopmental disorders.
Additionally, researchers discovered that genetic changes in cancer disrupt the proper functioning of the DDX3X protein, offering implications for developing novel cancer treatments targeting this gene.
Collectively, these findings advance our understanding of the mechanisms underlying neurodevelopmental disorders and cancer. They equip clinicians with valuable insights into the potential repercussions of genetic changes in DDX3X on a child’s health, facilitating earlier diagnosis.
“In the context of genetic conditions, even minor changes in the genetic code can have profound implications for a child’s development.
Our approach, which goes beyond computation to assess protein function, overcomes this diagnostic challenge to reliably distinguish between harmless and harmful rare genetic changes.
We hope to apply this technique to other genes, unlocking essential insights hidden within our genetic code,” says Dr. Sebastian Gerety.
“DDX3X is altered in a range of cancers and, in particular, in childhood brain cancers. Understanding exactly which mutations are disease-causing facilitates diagnosis and can help ensure patients get the most suitable treatment for their disease,” says Dr. David Adams.
“Genetic testing is increasingly integrated into patient care, yet our ability to decode the genetic information has not kept pace, preventing families from receiving the full support they need.
These freely available insights will empower doctors to interpret genetic tests and diagnose children earlier, enabling timely intervention and improved quality of life for those affected by DDX3X-linked neurodevelopmental disorders,” says Dr. Elizabeth Radford.
If you care about brain health, please read studies about how the Mediterranean diet could protect your brain health, and Omega-3 fats and carotenoid supplements could improve memory.
For more information about brain health, please see recent studies about antioxidants that could help reduce dementia risk, and higher magnesium intake could help benefit brain health.
The research findings can be found in Nature Communications.
Copyright © 2023 Knowridge Science Report. All rights reserved.
